Andrographolide regulates H3 histone lactylation by interfering with p300 to alleviate aortic valve calcification
British Journal of Pharmacology · 2024
DOI: 10.1111/bph.16332 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2024. Verfasst von Chunli Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan, China. Hauptthemen laut MEDLINE: Aortic Valve, Aortic Valve Stenosis, Calcinosis, Diterpenes. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hubei Province Health and Family Planning Scientific Research Project, Young Elite Scientists Sponsorship Program by the China Association of Chinese Medicine.
Abstract (Originalsprache)
Background and Purpose Our previous studies have found that andrographolide (AGP) alleviates calcific aortic valve disease (CAVD), but the underlying mechanism is unclear. This study explores the molecular target and signal mechanisms of AGP in inhibiting CAVD. Experimental Approach The anti‐calcification effects of the aortic valve with AGP treatment were evaluated by alizarin red staining in vitro and ultrasound and histopathological assessment of a high‐fat (HF)‐fed ApoE −/− mouse valve calcification model. A correlation between the H3 histone lactylation (H3Kla) and calcification was detected. Molecular docking and surface plasmon resonance (SPR) experiments were further used to confirm p300 as a target for AGP. Overexpression (oe) and silencing (si) of p300 were used to verify the inhibitory effect of AGP targeting p300 on the H3Kla in vitro and ex vivo. Key Results AGP significantly inhibited calcium deposition in valve interstitial cells (VICs) and ameliorated aortic valve calcification. The multi‐omics analysis revealed the glycolysis pathway involved in CAVD, indicating that AGP interfered with lactate production by regulating lactate dehydrogenase A (LDHA). In addition, lactylation, a new post‐translational modification, was shown to have a role in promoting aortic valve calcification. Furthermore, H3Kla and H3K9la site were shown to correlate with Runx2 expression inhibition by AGP treatment. Importantly, we found that p300 transferase was the molecular target of AGP in inhibiting H3Kla. Conclusions and Implications Our findings, for the first time, demonstrated that AGP alleviates calcification by interfering with H3Kla via p300, which might be a powerful drug to prevent CAVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan, China.
- Hubei Shizhen Laboratory, Wuhan, China.
- Hubei Provincial Engineering Technology Research Center for Chinese Medicine Processing, School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.
ORCID-Profile: Chunli Wang, Kang Xu
Förderung
- National Natural Science Foundation of China
- Hubei Province Health and Family Planning Scientific Research Project
- Young Elite Scientists Sponsorship Program by the China Association of Chinese Medicine
Zitieren
APA
Wang, C., Wang, S., Wang, Z., Han, J., Jiang, N., Qu, L., & Xu, K. (2024). Andrographolide regulates H3 histone lactylation by interfering with p300 to alleviate aortic valve calcification. British Journal of Pharmacology. https://doi.org/10.1111/bph.16332
Vancouver
Wang C, Wang S, Wang Z, Han J, Jiang N, Qu L, et al. Andrographolide regulates H3 histone lactylation by interfering with p300 to alleviate aortic valve calcification. British Journal of Pharmacology. 2024. doi:10.1111/bph.16332
BibTeX
@article{Wang2024,
author = {Wang, Chunli and Wang, Shunshun and Wang, Zijun and Han, Juanjuan and Jiang, Nan and Qu, Linghang and Xu, Kang},
title = {Andrographolide regulates H3 histone lactylation by interfering with p300 to alleviate aortic valve calcification},
journal = {British Journal of Pharmacology},
year = {2024},
doi = {10.1111/bph.16332}
}
EUVIMED